Skip to main content
Erschienen in: Archives of Virology 3/2017

05.11.2016 | Original Article

Position 22 of the V3 loop is associated with HIV infectivity

verfasst von: Xue-Mei Wei, Hua-Feng Xu, Xue-Di Cheng, Nan Bu, Hai-Zhou Zhou

Erschienen in: Archives of Virology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Human immunodeficiency virus subtype 1B (HIV-1B) binds to the CD4 receptor and co-receptor CCR5 or CXCR4 to enter T lymphocytes. The amino acid sequence of the HIV envelope glycoprotein V3 region determines the co-receptor tropism, thereby influencing the infectivity of the virus. Our research group previously found that the amino acid at position 22 of the V3 region may affect the infectivity of the virus, and in this study, we tested this hypothesis. We constructed pseudoviruses by changing the amino acids at position 22 of the V3 region in CCR5-tropic and CXCR4-tropic viruses and tested their infectivity. When the amino acid at V3 position 22 was altered in the CCR5- and CXCR4-tropic viruses, their ability to infect cells decreased to 20.6% and 17.14%, respectively. Therefore, we propose that residue 22 in the V3 region of subtype HIV-1B significantly influences the infectivity of the virus.
Literatur
1.
Zurück zum Zitat Delgado E, Fernandez-Garcia A, Vega Y, Cuevas T, Pinilla M, Garcia V, Sanchez M, Gonzalez M, Sanchez AM, Thomson MM, Perez-Alvarez L (2012) Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes. J Antimicrob Chemother 67:25–31CrossRefPubMed Delgado E, Fernandez-Garcia A, Vega Y, Cuevas T, Pinilla M, Garcia V, Sanchez M, Gonzalez M, Sanchez AM, Thomson MM, Perez-Alvarez L (2012) Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes. J Antimicrob Chemother 67:25–31CrossRefPubMed
2.
Zurück zum Zitat Coelho LP, Ferreira JL, Cabral GB, Guimaraes PM, Brigido LF (2014) Genotypic tropism prediction from paired cell and plasma using single and replicate sequences. AIDS Res Hum Retroviruses 30:711–716CrossRefPubMed Coelho LP, Ferreira JL, Cabral GB, Guimaraes PM, Brigido LF (2014) Genotypic tropism prediction from paired cell and plasma using single and replicate sequences. AIDS Res Hum Retroviruses 30:711–716CrossRefPubMed
3.
Zurück zum Zitat Aiamkitsumrit B, Dampier W, Antell G, Rivera N, Martin-Garcia J, Pirrone V, Nonnemacher MR, Wigdahl B (2014) Bioinformatic analysis of HIV-1 entry and pathogenesis. Curr HIV Res 12:132–161CrossRefPubMedPubMedCentral Aiamkitsumrit B, Dampier W, Antell G, Rivera N, Martin-Garcia J, Pirrone V, Nonnemacher MR, Wigdahl B (2014) Bioinformatic analysis of HIV-1 entry and pathogenesis. Curr HIV Res 12:132–161CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Dittmar MT, McKnight A, Simmons G, Clapham PR, Weiss RA, Simmonds P (1997) HIV-1 tropism and co-receptor use. Nature 385:495–496CrossRefPubMed Dittmar MT, McKnight A, Simmons G, Clapham PR, Weiss RA, Simmonds P (1997) HIV-1 tropism and co-receptor use. Nature 385:495–496CrossRefPubMed
5.
Zurück zum Zitat Schwalbe B, Schreiber M (2015) Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization. PLoS One 10:e0119879CrossRefPubMedPubMedCentral Schwalbe B, Schreiber M (2015) Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization. PLoS One 10:e0119879CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Berger EA, Murphy PM, Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17:657–700CrossRefPubMed Berger EA, Murphy PM, Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17:657–700CrossRefPubMed
7.
Zurück zum Zitat Koot M, van Leeuwen R, de Goede RE, Keet IP, Danner S, Eeftinck Schattenkerk JK, Reiss P, Tersmette M, Lange JM, Schuitemaker H (1999) Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis. J Infect Dis 179:254–258CrossRefPubMed Koot M, van Leeuwen R, de Goede RE, Keet IP, Danner S, Eeftinck Schattenkerk JK, Reiss P, Tersmette M, Lange JM, Schuitemaker H (1999) Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis. J Infect Dis 179:254–258CrossRefPubMed
8.
Zurück zum Zitat Poveda E, Briz V, Quinones-Mateu M, Soriano V (2006) HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors. AIDS 20:1359–1367CrossRefPubMed Poveda E, Briz V, Quinones-Mateu M, Soriano V (2006) HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors. AIDS 20:1359–1367CrossRefPubMed
9.
Zurück zum Zitat Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, Tersmette M (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 66:1354–1360PubMedPubMedCentral Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, Tersmette M (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 66:1354–1360PubMedPubMedCentral
10.
Zurück zum Zitat Nwankwo N, Seker H (2013) HIV progression to AIDS: bioinformatics approach to determining the mechanism of action. Curr HIV Res 11:30–42PubMed Nwankwo N, Seker H (2013) HIV progression to AIDS: bioinformatics approach to determining the mechanism of action. Curr HIV Res 11:30–42PubMed
11.
Zurück zum Zitat Huang CC, Lam SN, Acharya P, Tang M, Xiang SH, Hussan SS, Stanfield RL, Robinson J, Sodroski J, Wilson IA, Wyatt R, Bewley CA, Kwong PD (2007) Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317:1930–1934CrossRefPubMedPubMedCentral Huang CC, Lam SN, Acharya P, Tang M, Xiang SH, Hussan SS, Stanfield RL, Robinson J, Sodroski J, Wilson IA, Wyatt R, Bewley CA, Kwong PD (2007) Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317:1930–1934CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, Stanfield RL, Dimitrov DS, Korber B, Sodroski J, Wilson IA, Wyatt R, Kwong PD (2005) Structure of a V3-containing HIV-1 gp120 core. Science 310:1025–1028CrossRefPubMedPubMedCentral Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, Stanfield RL, Dimitrov DS, Korber B, Sodroski J, Wilson IA, Wyatt R, Kwong PD (2005) Structure of a V3-containing HIV-1 gp120 core. Science 310:1025–1028CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Jiang X, Burke V, Totrov M, Williams C, Cardozo T, Gorny MK, Zolla-Pazner S, Kong XP (2010) Conserved structural elements in the V3 crown of HIV-1 gp120. Nat Struct Mol Biol 17:955–961CrossRefPubMed Jiang X, Burke V, Totrov M, Williams C, Cardozo T, Gorny MK, Zolla-Pazner S, Kong XP (2010) Conserved structural elements in the V3 crown of HIV-1 gp120. Nat Struct Mol Biol 17:955–961CrossRefPubMed
15.
Zurück zum Zitat Stanfield RL, Wilson IA (2005) Structural studies of human HIV-1 V3 antibodies. Hum Antibodies 14:73–80PubMed Stanfield RL, Wilson IA (2005) Structural studies of human HIV-1 V3 antibodies. Hum Antibodies 14:73–80PubMed
16.
Zurück zum Zitat Zhang L, Ma L, Wang Z, Wang Y, Zhang J, Wang H, Shao Y (2014) Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China. PLoS One 9:e93426CrossRefPubMedPubMedCentral Zhang L, Ma L, Wang Z, Wang Y, Zhang J, Wang H, Shao Y (2014) Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China. PLoS One 9:e93426CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195–201CrossRefPubMed Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195–201CrossRefPubMed
18.
Zurück zum Zitat Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede T (2009) The SWISS-MODEL Repository and associated resources. Nucleic Acids Res 37:D387–D392CrossRefPubMed Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede T (2009) The SWISS-MODEL Repository and associated resources. Nucleic Acids Res 37:D387–D392CrossRefPubMed
19.
Zurück zum Zitat Zhou HZ, Xu HF, Xin XM, Guan XR, Zhou J (2011) Position 22 of the V3 loop is associated with co-receptor usage and disease progression in HIV-1 subtype B isolates. Curr HIV Res 9:636–641CrossRefPubMed Zhou HZ, Xu HF, Xin XM, Guan XR, Zhou J (2011) Position 22 of the V3 loop is associated with co-receptor usage and disease progression in HIV-1 subtype B isolates. Curr HIV Res 9:636–641CrossRefPubMed
20.
Zurück zum Zitat Gazarian KG, Palacios-Rodriguez Y, Gazarian TG, Huerta L (2013) HIV-1 V3 loop crown epitope-focused mimotope selection by patient serum from random phage display libraries: implications for the epitope structural features. Mol Immunol 54:148–156CrossRefPubMed Gazarian KG, Palacios-Rodriguez Y, Gazarian TG, Huerta L (2013) HIV-1 V3 loop crown epitope-focused mimotope selection by patient serum from random phage display libraries: implications for the epitope structural features. Mol Immunol 54:148–156CrossRefPubMed
21.
Zurück zum Zitat Cormier EG, Dragic T (2002) The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J Virol 76:8953–8957CrossRefPubMedPubMedCentral Cormier EG, Dragic T (2002) The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J Virol 76:8953–8957CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Lobritz MA, Marozsan AJ, Troyer RM, Arts EJ (2007) Natural variation in the V3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivity. J Virol 81:8258–8269CrossRefPubMedPubMedCentral Lobritz MA, Marozsan AJ, Troyer RM, Arts EJ (2007) Natural variation in the V3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivity. J Virol 81:8258–8269CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Almond D, Kimura T, Kong X, Swetnam J, Zolla-Pazner S, Cardozo T (2010) Structural conservation predominates over sequence variability in the crown of HIV type 1’s V3 loop. AIDS Res Hum Retroviruses 26:717–723CrossRefPubMedPubMedCentral Almond D, Kimura T, Kong X, Swetnam J, Zolla-Pazner S, Cardozo T (2010) Structural conservation predominates over sequence variability in the crown of HIV type 1’s V3 loop. AIDS Res Hum Retroviruses 26:717–723CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Sander O, Sing T, Sommer I, Low AJ, Cheung PK, Harrigan PR, Lengauer T, Domingues FS (2007) Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage. PLoS Comput Biol 3:e58CrossRefPubMedPubMedCentral Sander O, Sing T, Sommer I, Low AJ, Cheung PK, Harrigan PR, Lengauer T, Domingues FS (2007) Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage. PLoS Comput Biol 3:e58CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Briz V, Poveda E, Soriano V (2006) HIV entry inhibitors: mechanisms of action and resistance pathways. J Antimicrob Chemother 57:619–627CrossRefPubMed Briz V, Poveda E, Soriano V (2006) HIV entry inhibitors: mechanisms of action and resistance pathways. J Antimicrob Chemother 57:619–627CrossRefPubMed
27.
Zurück zum Zitat Cormier EG, Tran DN, Yukhayeva L, Olson WC, Dragic T (2001) Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes. J Virol 75:5541–5549CrossRefPubMedPubMedCentral Cormier EG, Tran DN, Yukhayeva L, Olson WC, Dragic T (2001) Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes. J Virol 75:5541–5549CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Obermeier M, Symons J, Wensing AM (2012) HIV population genotypic tropism testing and its clinical significance. Curr Opin HIV AIDS 7:470–477CrossRefPubMed Obermeier M, Symons J, Wensing AM (2012) HIV population genotypic tropism testing and its clinical significance. Curr Opin HIV AIDS 7:470–477CrossRefPubMed
29.
Zurück zum Zitat Chabot DJ, Chen H, Dimitrov DS, Broder CC (2000) N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates. J Virol 74:4404–4413CrossRefPubMedPubMedCentral Chabot DJ, Chen H, Dimitrov DS, Broder CC (2000) N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates. J Virol 74:4404–4413CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Bozek K, Lengauer T, Sierra S, Kaiser R, Domingues FS (2013) Analysis of physicochemical and structural properties determining HIV-1 coreceptor usage. PLoS Comput Biol 9:e1002977CrossRefPubMedPubMedCentral Bozek K, Lengauer T, Sierra S, Kaiser R, Domingues FS (2013) Analysis of physicochemical and structural properties determining HIV-1 coreceptor usage. PLoS Comput Biol 9:e1002977CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Chandramouli B, Chillemi G, Giombini E, Capobianchi MR, Rozera G, Desideri A (2013) Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120. J Biomol Struct Dyn 31:403–413CrossRefPubMed Chandramouli B, Chillemi G, Giombini E, Capobianchi MR, Rozera G, Desideri A (2013) Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120. J Biomol Struct Dyn 31:403–413CrossRefPubMed
32.
Zurück zum Zitat Mayr LM, Zolla-Pazner S (2015) Antibodies targeting the envelope of HIV-1. Microbiol Spectr 3:AID-0025-2014 Mayr LM, Zolla-Pazner S (2015) Antibodies targeting the envelope of HIV-1. Microbiol Spectr 3:AID-0025-2014
33.
Zurück zum Zitat Zolla-Pazner S, Cohen SS, Boyd D, Kong XP, Seaman M, Nussenzweig M, Klein F, Overbaugh J, Totrov M (2016) Structure/function studies involving the V3 region of the HIV-1 envelope delineate multiple factors that affect neutralization sensitivity. J Virol 90:636–649CrossRef Zolla-Pazner S, Cohen SS, Boyd D, Kong XP, Seaman M, Nussenzweig M, Klein F, Overbaugh J, Totrov M (2016) Structure/function studies involving the V3 region of the HIV-1 envelope delineate multiple factors that affect neutralization sensitivity. J Virol 90:636–649CrossRef
34.
Zurück zum Zitat Suphaphiphat P, Essex M, Lee TH (2007) Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor. Virology 360:182–190CrossRefPubMed Suphaphiphat P, Essex M, Lee TH (2007) Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor. Virology 360:182–190CrossRefPubMed
Metadaten
Titel
Position 22 of the V3 loop is associated with HIV infectivity
verfasst von
Xue-Mei Wei
Hua-Feng Xu
Xue-Di Cheng
Nan Bu
Hai-Zhou Zhou
Publikationsdatum
05.11.2016
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 3/2017
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-016-3138-7

Weitere Artikel der Ausgabe 3/2017

Archives of Virology 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.